Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokomb éré, Cameroon in Pregnant Women
Condition: Hepatitis B Virus - Chronic Active Intervention: Drug: Fumarate, Tenofovir Disoproxil Sponsor: ANRS, Emerging Infectious Diseases Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials
Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates
Conditions: Lung Transplant; Hepatitis B Intervention: Drug: Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide Sponsor: University of Pennsylvania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials
Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokomb éré, Cameroon in Pregnant Women
Condition: Hepatitis B Virus - Chronic Active Intervention: Drug: Fumarate, Tenofovir Disoproxil Sponsor: ANRS, Emerging Infectious Diseases Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials
Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates
Conditions: Lung Transplant; Hepatitis B Intervention: Drug: Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide Sponsor: University of Pennsylvania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials
Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokomb éré, Cameroon in Pregnant Women
Condition: Hepatitis B Virus - Chronic Active Intervention: Drug: Fumarate, Tenofovir Disoproxil Sponsor: ANRS, Emerging Infectious Diseases Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials
Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates
Conditions: Lung Transplant; Hepatitis B Intervention: Drug: Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide Sponsor: University of Pennsylvania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2022 Category: Research Source Type: clinical trials
An Experimental Study on the Effect of Tenofovir Amibufenamide on Blood Lipid During Anti-HBV Treatment
Conditions: Hepatitis B, Chronic; Lipid Disorder Interventions: Drug: oral Tenofovir Amibufenamide 25mg each day; Drug: lipid lowering drugs (e.g. Atorvastatin and amlodipine.) Sponsor: Wuhan Union Hospital, China Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2022 Category: Research Source Type: clinical trials